SCHEMBL9627637

SCHEMBL9627637

CCOC1=C(CC)C(=O)c2c(F)cccc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ PTPRC P08575 2/20 0.37
▸ CDC25B P30305 1/20 0.37
▸ TTR P02766 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ ELANE P08246 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ CCR6 P51684 1/20 0.35
▸ HKDC1 Q2TB90 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9629324 0.81 MAPT (0.39) CDC25BKDM4EALDH1A1ELANECA1
SCHEMBL9627536 0.78 CDC25B (0.53) L3MBTL1PTPRCCDC25BKDM4EALDH1A1
SCHEMBL9627403 0.76 CA1 (0.37) L3MBTL1KDM4EALDH1A1ELANECA1
SCHEMBL10019961 0.74 PTPRC (0.41) L3MBTL1PTPRCCDC25BTTRKDM4E
SCHEMBL10716838 0.73 MAOA (0.52) L3MBTL1PTPRCCDC25BTTRALDH1A1
SCHEMBL8916299 0.71 MAPT (0.54) L3MBTL1PTPRCCDC25BTTRKDM4E
SCHEMBL3420371 0.69 CDC25B (0.60) L3MBTL1PTPRCCDC25BKDM4EALDH1A1
SCHEMBL5866470 0.69 CA1 (0.52) PTPRCCDC25BTTRKDM4EALDH1A1
SCHEMBL13487412 0.69 CA1 (0.52) L3MBTL1PTPRCCDC25BTTRKDM4E
SCHEMBL9641755 0.69 ADORA2A (0.55) L3MBTL1PTPRCCDC25BTTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 — — US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 — — US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 — — US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 — — US disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 — — US disclosed
Send feedback